Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Cancer Immunol Res. 2018 Jul 10;6(9):1093–1099. doi: 10.1158/2326-6066.CIR-17-0755

Figure 2. Treatment exposure and response duration in the retreatment cohort.

Figure 2.

Colored solid bars: best objective response of each patient (n=38). Stars: objective response documented after retreatment. Arrow: ongoing treatment; Circle: retreatment date; Triangle: first objective response.